IMPROVEMENT AND SAVINGS OBTAINED WITH A PROJECT IN A SPANISH REGIONAL HEALTH SERVICE

Transcripción

1 IMPROVEMENT AND SAVINGS OBTAINED WITH A PROJECT IN A SPANISH REGIONAL HEALTH SERVICE CIMA AP FARMACIA 1

2 Cuadro de Mandos 2

3 CIMA ap FARMACIA What? Needed infomation(return) Who? Central Office in chargeof: Information(mismo formato e indicadores) Delivery to the owner HealthÁreas in chargeof: Implementation and following-up in its own territory Whom? Heath Area Managers and Pharmacysts Prescriptor: Primary Care FD y Pediatrician Sent streight from SMS Central Office 2 closedenvelops(fd and Ped) with alltheinformationto Health Center Director who delivers them to the physicians 3

4 CIMA ap FARMACIA How? Comparative (group, not alone) Visibility, recognition, benchmark When? Monthly Data are 3 monthsold: 1. Prescription 2. Delivery at Chemisit s(1 month) 3.ChargingtoSMS (endoof themonth) 4.Carga en Faceta(depende de nº de incidencias a resolver) 5.Carga en AdN 6. CIMA What for? Improvement list 4

5 REPORT DIMENSIONS: Primay Care Pediatrician Family doctor 22 de abril de

6 PEDIATRICIANS: 6 IndicatorsMC 2010 Active Drug Principle Salbutamol Antibiotics DHD Penicilin LIMIT amoxi-clavulanic LMIT macrolidos 22 de abril de

7 FAMILY DOCTORS 6 INDICATORS MC 2010 Active Drug Principle Antibiotic DHD Omeprazol IECA Simvastatin β2-corticoides Associations 7

8 MÉDICO DE FAMILIA 8

9 MÉDICO DE FAMILIA 22 de abril de

10 CIMA AP Farmacia: Resultados 10

11 Results 1. Satisfaction Survey: Good 2. Improvement: a) Historic compliance: Since 2005 b) Improvement(same month previous year): since 2009 SMS Indicators Health Areas 3. Savings: a. Priorised groups b. Global 11

12 SatisfactionSurvey CIMA AP Farmacia 12

13 SatisfactionSurvey CIMA AP Farmacia Asessement per indicator: 13

14 SMS Mean Compliance 01/ /

15 SMS Improvement: Same month previous year 01/ /

16 FAMILY DOCTOR: 6 Indicators2010 MC-P Active Principle AntibioticDHD Omeprazol IECA Simvastatin β2-corticoids Association 16

17 Improvementper Indicator: Active Principle 17

18 IndicatorImprovement: IECA 18

19 Indicatorimprovement: Beta-2 Assoc 19

20 IndicatorImprovemente: Omeprazol 20

21 IndicatorImprovement: Simvastatine 21

22 HealthAreaImprovement 22

23 Accumulativ. Improv

24 FD improvementper HC -2,00-1,00 0,00 1,00 2,00 3,00 4,00 5,00 6,00-0,92-0,72-0,53 EAP Cehegín EAP Blanca EAP Abarán EAP Cieza EAP Los Dolores EAP Algezares EAP Sangonera La Verde EAP Torre Pacheco Este EAP Puerto Lumbreras EAP Águilas Sur EAP Puente Tocinos EAP Alguazas EAP Yecla Oeste EAP Beniel EAP Ceutí EAP Barranda EAP Molinos Marfagones EAP Bullas EAP Los Alcázares EAP Molina Sur EAP Fortuna EAP Torres de Cotillas EAP Monteagudo EAP Alhama EAP Fuente Álamo EAP Jumilla EAP Caravaca EAP Alquerías EAP Archena EAP Santomera EAP Torre Pacheco Oeste EAP Nonduermas EAP Yecla Este EAP Santa Mª de Gracia EAP Cartagena Casco EAP Llano de Brujas EAP Beniaján EAP Mula EAP San Andrés EAP Vistalegre EAP Cartagena Este EAP Espinardo EAP Murcia Centro EAP Alcantarilla S.laSeca EAP La Manga EAP San Javier EAP Zarandona EAP Cabezo de Torres EAP Alcantarilla Casco EAP El Palmar EAP Santa Lucía EAP Infante Juan Manuel EAP Calasparra EAP Barrio Peral EAP La Unión EAP Cartagena Oeste EAP Moratalla EAP Abanilla EAP San Antón EAP Pozo Estrecho EAP La Alberca EAP Barrio del Carmen EAP Totana EAP Campo de Cartagena EAP Mazarrón EAP Molina Norte EAP Los Barreros EAP Mar Menor EAP Lorca Centro EAP San Pedro del Pinatar EAP Lorca San José EAP Puerto de Mazarrón EAP -0,05 Vistabella EAP Lorca -0,06 San Diego -0,06 EAP Lorquí -0,22EAP Águilas Norte EAP La Ñora EAP La Paca EAP El Ranero 0,27 0,26 0,21 0,16 0,14 0,53 0,53 0,46 1,74 1,70 1,64 1,61 1,58 1,57 1,48 1,46 1,45 1,39 1,35 1,34 1,32 1,31 1,29 1,29 1,26 1,21 1,17 1,17 1,13 1,13 1,09 0,99 0,97 0,90 0,86 0,84 0,83 0,83 0,83 0,82 0,79 0,77 0,76 0,76 0,74 0,73 0,72 0,67 0,65 1,97 1,95 1,91 1,91 2,39 2,29 2,21 2,14 2,09 2,54 2,53 2,52 2,67 2,90 2,82 2,79 2,79 2,77 3,54 3,50 3,42 4,44 5,38 24

25 25

26 EXPENDITURE: Grouped Active Principles 26

27 Saving NO OmeprazolPPI 27

28 Savings ARA-II 28

29 Savings Statins 29

30 Savings β2-corticoids FixedAssocia 30

31 Savings Antibiotics 31

32 GLOBAL SAVINGS CIMA AP Farmacia 32

33 Savingsin priorisedgroups 33

34 Conclusions 1. Information if well addressed is the biggest incentive. 2. Visibility and comparison between pairs offer benchmarking. 3. Itiskeyissuetogettheinvolvementand commitment of the actors of the process to implement change(human factor) 34

35 XVII Congreso Regional de Medicina Familiar y Comunitaria 35

36 XVII Congreso Regional de Medicina Familiar y Comunitaria 36